Major Adverse Cardiovascular Events Related to Jak Inhibitors: A Disproportionality Analysis Using WHO Global Individual Case Safety Database
Idioma
EN
Communication dans un congrès
Este ítem está publicado en
Drug Safety, 23rd Annual Meeting of the Global Perspectives on Pharmacovigilance in the Digital Age and Advanced Therapeutics (ISoP), 2024-10-01, Montréal. 2024-12-01, vol. 47, n° 12, p. 1395-1395